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Abstract
Background: Understanding what influences people to seek help can inform interventions to promote earlier
diagnosis of cancer, and ultimately better cancer survival. We aimed to examine relationships between negative
cancer beliefs, recognition of cancer symptoms and how long people think they would take to go to the doctor
with possible cancer symptoms (anticipated patient intervals).
Methods: Telephone interviews of 20,814 individuals (50+) in the United Kingdom, Australia, Canada, Denmark,
Norway and Sweden were carried out using the Awareness and Beliefs about Cancer Measure (ABC). ABC included
items on cancer beliefs, recognition of cancer symptoms and anticipated time to help-seeking for cough and rectal
bleeding. The anticipated time to help-seeking was dichotomised as over one month for persistent cough and over
one week for rectal bleeding.
Results: Not recognising persistent cough/hoarseness and unexplained bleeding as cancer symptoms increased
the likelihood of a longer anticipated patient interval for persistent cough (OR = 1.66; 95%CI = 1.47–1.87) and rectal
bleeding (OR = 1.90; 95%CI = 1.58–2.30), respectively. Endorsing four or more out of six negative beliefs about
cancer increased the likelihood of longer anticipated patient intervals for persistent cough and rectal bleeding (OR
= 2.18; 95%CI = 1.71–2.78 and OR = 1.97; 95%CI = 1.51–2.57). Many negative beliefs about cancer moderated the
relationship between not recognising unexplained bleeding as a cancer symptom and longer anticipated patient
interval for rectal bleeding (p = 0.005).
Conclusions: Intervention studies should address both negative beliefs about cancer and knowledge of symptoms
to optimise the effect.
Keywords: Behavioural medicine, Primary health care, Surveys and questionnaires, Telephone
Background
Diagnosis of cancer at an early stage is important to op-
timise the outcomes of cancer [1]. A study of more than
2000 patients with 15 different cancers showed that 21%
had delayed symptomatic presentation for more than
three months [2]. Therefore, improvement of our
understanding of individuals’ decision to seek medical
help for symptoms that could be a sign of cancer is very
important.
The patient interval is defined as the time period be-
tween an individual’s first discovery of a change in the
body and the first consultation with a healthcare profes-
sional, often the general practitioner [1]. Cognitive fac-
tors such as knowledge about disease and symptoms
seem to play a role in decision-making about healthcare
seeking [3–5]. For instance, cancer patients who did not
perceive their initial symptoms as serious were twice as
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likely to postpone help-seeking for at least three months
[2]. Nevertheless, there is often a gap between know-
ledge and behaviour, with knowledge about cancer
symptoms not entirely predictive of help-seeking behav-
iour [6, 7]. The relationship between negative cancer be-
liefs (NCBs) and help-seeking for a symptom which may
be a sign of cancer has been under-researched.
The aim of this paper was to explore the influence of
NCBs on the likelihood of long anticipated patient inter-
vals for persistent cough and rectal bleeding. Persistent
cough and rectal bleeding may be signs of lung cancer
and colorectal cancer, respectively, and these two can-
cers strike both men and women. They are two of the
most common cancers, yet their symptoms may be per-
ceived as less alarming or less specific to cancer than
“classic” symptoms such as a lump. First, we examined
the association between NCBs about cancer and longer
anticipated patient intervals for persistent cough and
rectal bleeding while adjusting for symptom recognition
(see Fig. 1a). Second, we examined whether NCBs about
cancer have a moderating influence on the association
between not recognising persistent cough/hoarseness or
unexplained bleeding as possible signs of cancer and a
long anticipated patient interval for persistent cough and
rectal bleeding, respectively (see Fig. 1b).
Methods
Data were used from a survey conducted as part of
the International Cancer Benchmarking Partnership
(ICBP) which was initiated to study international
variation in cancer survival. Module 2 of the ICBP
measured population awareness and beliefs about
cancer [8]. Data were collected from May to Septem-
ber 2011 [9] in six countries: the United Kingdom
(England, Wales and Northern Ireland), Australia
(New South Wales and Victoria), Canada, Denmark,
Norway and Sweden.
Computer-assisted telephone interviews were car-
ried out by the research market company Ipsos
MORI. All men and women aged 50 years or more
living in private households and able to understand
the official language of the country were eligible.
The researchers aimed to achieve a sample size of
2000 respondents in each country or jurisdiction,
and a total of 20,814 respondents participated. Data
collection and response rates have been described in
detail elsewhere [9–11].
NCBs, recognition of cancer symptoms and antici-
pated help-seeking were assessed by the internationally
developed and validated Awareness and Beliefs about
Cancer Measure (ABC) [12].
a
b
Fig. 1 Models of negative cancer beliefs as either independent variable or effect moderator. a Independent effects of negative beliefs about
cancer and recognition of cancer symptoms on anticipated patient intervals. b Negative beliefs about cancer as an effect moderator of the
association between recognition of cancer symptoms and length of the anticipated patient interval
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Dependent variable: anticipated time to help-seeking for
persistent cough and rectal bleeding
Four items from the ABC assessed the anticipated pa-
tient interval for symptoms that could be signs of can-
cer. In the present study, lung cancer and colorectal
cancer were the two target cancers and the anticipated
patient intervals for these two cancers were assessed by
asking the respondents how long they would wait before
seeking help after experiencing a persistent cough and
rectal bleeding, respectively. No standardised and inter-
nationally accepted guidelines are available about when
to seek help for these symptoms. As presented in Table 1,
anticipated patient intervals of more than one month for
persistent cough and of more than one week for rectal
bleeding were categorised as “long”. These cut-offs were
chosen for two reasons. First they ensured that we had
enough subjects in our “long” and “short” patient inter-
val categories. Second, cut-offs appeared reasonable as
everyone experiences a cough now and then and the
duration of the symptom plays an important role when
determining whether the cough needs medical attention.
On the contrary, rectal bleeding happening more than
once should always cause concern.
Independent variable: recognition of persistent cough or
hoarseness and unexplained bleeding as cancer
symptoms
The ABC included 11 possible cancer symptoms and re-
spondents were asked to determine whether they
thought that each symptom could be a warning sign of
cancer. The warning signs most closely related to the
two target cancers were persistent cough or hoarseness
and unexplained bleeding. Response options and coding
are shown in Table 1.
Independent variable and hypothesised moderator:
negative cancer beliefs (NCBs)
Six statements examined respondents’ beliefs about can-
cer. The wording, response options and coding are
shown in Table 1. The number of NCBs endorsed was
summed for each respondent. As the proportion of re-
spondents declaring five or six NCBs was limited (0.5%),
the survey data from these respondents were grouped
with the survey data from respondents declaring four
NCBs to ensure sufficient statistical power.
Demographic characteristics
Data were collected on sex, age (categorised as 50 to
59 years, 60 to 69 years, 70 to 79 years and 80 years or
older), marital status (categorised as married/cohabiting
vs. single/divorced/separated/widowed), highest level of
education (categorised as no university degree vs. uni-
versity degree), experience of cancer themselves and/or
in family/friend (categorised as yes/no), country and
smoking status (categorised as never/former vs. current).
Smokers have been shown to declare more NCBs than
non-smokers [13].
Statistics
The associations between non-recognition of persistent
cough or hoarseness and unexplained bleeding as cancer
symptoms, number of NCBs about cancer and long an-
ticipated patient intervals for persistent cough and rectal
bleeding, respectively, were examined in two separate lo-
gistic regression analyses. Odds ratios (ORs) were calcu-
lated as measures of association. In the adjusted
analyses, both non-recognition of symptom and number
of NCBs were included as independent variables and
sex, age, marital status, highest level of education, smok-
ing status, experience of cancer and country were in-
cluded as co-variables. As a sensitivity analysis, the
logistic regression analyses were repeated with the an-
swer “don’t know” to the questions about whether per-
sistent cough or hoarseness and unexplained bleeding
could be signs of cancer coded as “non-recognition” in-
stead of missing. To test for a moderating effect of NCBs
on the association between non-recognition of the
symptoms and length of anticipated patient intervals,
two interaction terms were computed: non-recognition
of persistent cough or hoarseness as a cancer symptom
multiplied with the number of NCBs and non-
recognition of unexplained bleeding as a cancer symp-
tom multiplied with the number of NCBs. These two
interaction terms were included in two separate logistic
regression analyses which also included independent and
demographic variables. The likelihood-ratio (LR) test
was used to determine whether the models with and
without the interaction terms were statistically signifi-
cantly different. In case of a statistically significant inter-
action, predictive margins would be used to visualise the
effect and to assist interpretation (https://www.cscu.cor-
nell.edu/news/statnews/stnews84.pdf ). P-values of 5% or
less were considered statistically significant. Data were
analysed using STATA 13.1.
Results
Demographic characteristics and proportion of respon-
dents with none to four or more NCBs are shown in
Table 2 (see additional file 1 for these results reported
for each country).
Not recognising persistent cough or hoarseness as a
possible sign of cancer (OR = 1.66, 95% CI = 1.47–1.
87) and a high number of NCBs (OR≥ 4 NCBs = 2.18,
95% CI = 1.71–2.78) were independently associated
with an increased likelihood of a longer anticipated
patient interval for persistent cough (Table 3). Not
recognising unexplained bleeding as a possible sign of
cancer (OR = 1.90, 95% CI = 1.58–2.30) and a high
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number of NCBs (OR≥ 4 NCBs = 1.97, 95% CI = 1.51–
2.57) were independently associated with an increased
likelihood of a longer anticipated patient interval for
rectal bleeding (Table 4). In both models, there was a
dose-response relationship between the number of
NCBs and the likelihood of a longer anticipated pa-
tient interval.
The results of the sensitivity analysis (the answer
“don't know” coded as “non-recognition” of symptom in-
stead of missing) confirmed a statistically independent
influence of non-recognition of symptoms (ORpersistent
cough = 1.57, 95% CI = 1.40–1.77; ORrectal bleeding = 1.70,
95% CI = 1.43–2.01) and number of NCBs (ORpersistent
cough = 2.27, 95% CI = 1.79–2.89; ORrectal bleeding = 1.98,
Table 1 Responses to questions about anticipated patient intervals and symptom awareness and how they were classified
Dependent variables: Anticipated patient intervals
How long would it take you to go to the
doctor from the first time you noticed a
persistent cough?
How long would it take you to go to the doctor
from the first time you noticed rectal bleeding?
Response categories: N (%) Classification N (%) Classification
I would go as soon as I noticed 2669 (12.8) Short pt. interval 12,617 (60.6) Short pt. interval
Up to 1 week 3750 (18.0) Short pt. interval 5017 (24.1) Short pt. interval
Over 1 up to 2 weeks 4029 (19.4) Short pt. interval 1323 (6.4) Long pt. interval
Over 2 up to 3 weeks 3001 (14.4) Short pt. interval 518 (2.5) Long pt. interval
Over 3 up to 4 weeks 2557 (12.3) Short pt. interval 357 (1.7) Long pt. interval
More than a month 3267 (15.7) Long pt. interval 488 (2.3) Long pt. interval
I would not contact a/my doctor 844 (4.1) Long pt. interval 171 (0.8) Long pt. interval
I would go to another HCP 320 (1.5) Missing 141 (0.7) Missing
Don’t know 355 (1.7) Missing 164 (0.8) Missing
Don’t want to answer 22 (0.1) Missing 18 (0.1) Missing
Independent variables: Recognition of symptoms as cancer symptoms
Do you think persistent cough or hoarseness
could be a warning sign for cancer?
Do you think unexplained bleeding could be a warning
sign for cancer?
Response categories: N (%) Classification N (%) Classification
Yes 15,155 (72.8) Recognition 18,187 (87.4) Recognition
No 4951 (23.8) Non-recognition 2018 (9.7) Non-recognition
Don’t know 693 (3.3) Missing 598 (2.9) Missing
Don’t want to answer 15 (7.2) Missing 11 (0.0) Missing
Independent variable/moderator: Negative cancer beliefs (NCBs)
Answers classified as NCBs are highlighted in bold.
The answers “don’t know” and “don’t want to answer” were classified as missing.
Strongly disagree or tend to disagree Strongly agree or tend to agree Don’t know or refused
N (%) N (%) N (%)
People with cancer can expect to
continue with normal activities
1936 (9.3) 18,187 (87.4) 691 (3.3)
Cancer can often be cured 1853 (8.9) 18,502 (88.9) 459 (2.2)
Going to the doctor as quickly as
possible after noticing a symptom
of cancer could increase the
chances of surviving
394 (1.9) 20,310 (97.6) 110 (0.5)
Cancer treatment is worse than the
cancer itself
7196 (34.6) 11,082 (53.2) 2536 (12.2)
I would not want to know if I have cancer 18,004 (86.5) 2337 (11.2) 473 (2.3)
A diagnosis of cancer is a death sentence 14,995 (72.0) 5110 (24.6) 709 (3.4)
HCP = Healthcare professional; pt. = patient
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95% CI = 1.53–2.58) on the likelihood of a long antici-
pated patient interval for persistent cough and rectal
bleeding (adjusted analyses, data not shown).
No statistically significant interaction effect of NCBs
and not recognising cough or hoarseness on the likeli-
hood of a long anticipated patient interval for persistent
cough was revealed in the moderation analysis (Table 3).
However, the moderation analysis revealed a significant
interaction of NCBs with non-recognition of unex-
plained bleeding on the likelihood of a long anticipated
patient interval for rectal bleeding, and the likelihood-
ratio test confirmed that the statistical model with the
interaction term was significantly different from the
model without the interaction term (LR chi2 = 7.97, p =
0.005; Table 4). In Fig. 2, the predicted probabilities of
reporting a long anticipated patient interval for rectal
Table 2 Description of the sample
All Females Males
N = 20,814 (100%) N = 12,456 (59.8%) N = 8358 (40.2%)
Age group, n (%)
50–59 years 7375 (35.4) 4414 (35.4) 2961 (35.4)
60–69 years 7510 (36.1) 4416 (35.5) 3094 (37.0)
70–79 years 4234 (20.3) 2564 (20.6) 1670 (20.0)
≥ 80 years 1695 (8.1) 1062 (8.5) 633 (7.6)
Marital status
Cohabiting 12,665 (60.9) 6747 (54.2) 5918 (70.8)
Single 8082 (38.8) 5665 (45.5) 2417 (28.9)
Education
No university degree 14,334 (68.9) 8911 (71.5) 5423 (64.9)
University degree 6331 (30.4) 3448 (27.7) 2883 (34.5)
Smoking status
Not current smoker 17,600 (84.6) 10,605 (85.1) 6995 (83.7)
Current smoker 3207 (15.4) 1847 (14.8) 1360 (16.3)
Experience of cancer (self and/or family/friend)
Yes 17,157 (82.4) 10,698 (85.9) 6459 (77.3)
No 3629 (17.4) 1745 (14.0) 1884 (22.5)
Anticipated interval for persistent cough
Short 16,006 (76.9) 9578 (76.9) 6428 (76.9)
Long (> 1 month) 4111 (19.8) 2466 (19.8) 1645 (19.7)
Anticipated interval for rectal bleeding
Short 17,634 (84.7) 10,588 (85.0) 7046 (84.3)
Long (> 1 week) 2857 (13.7) 1675 (13.5) 1182 (14.1)
Recognition of persistent cough or hoarseness as cancer symptom
Yes 15,155 (72.8) 9501 (76.3) 5654 (67.7)
No 4951 (23.8) 2558 (20.5) 2393 (28.6)
Recognition of unexplained bleeding as cancer symptom
Yes 18,187 (87.4) 11,157 (89.6) 7030 (84.1)
No 2018 (9.7) 1005 (8.1) 1013 (12.1)
Number of negative cancer beliefs (coded as)
0 (0) 6427 (30.9) 3420 (27.5) 3007 (36.0)
1 (1) 8412 (40.4) 5225 (42.0) 3187 (38.1)
2 (2) 4180 (20.1) 2682 (21.5) 1498 (17.9)
3 (3) 1347 (6.5) 849 (6.8) 498 (6.0)
4–6 (> 4) 448 (2.2) 280 (2.3) 168 (2.0)
Sums vary because of missing data
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Table 3 Associations between recognition of persistent cough or hoarseness as cancer symptom, negative beliefs about cancer and
long anticipated patient interval for persistent cough (nadjusted = 19,277)
Unadjusted Adjusted*
Outcome: long anticipated patient
interval for cough (> 1 month)
Outcome: long
anticipated patient
interval for cough
(> 1 month)
Proportion with
long interval (%)
OR 95% CI P-value OR 95% CI P-value
Recognition of persistent cough or hoarseness as cancer symptom
Yes 18.5 Ref. Ref.
No 26.7 1.60 1.49–1.73 < 0.001 1.66 1.47–1.87 < 0.001
Number of negative beliefs about cancer
0 19.8 Ref. Ref.
1 19.3 0.97 0.89–1.05 0.453 0.97 0.89–1.06 0.522
2 20.7 1.05 0.95–1.16 0.312 1.06 0.95–1.19 0.305
3 24.5 1.31 1.14–1.51 < 0.001 1.33 1.13–1.57 0.001
≥ 4 36.3 2.31 1.87–2.84 < 0.001 2.18 1.71–2.78 < 0.001
Age group
50–59 years 23.1 Ref. Ref.
60–69 years 21.3 0.90 0.84–0.98 0.012 0.93 0.86–1.01 0.087
70–79 years 17.0 0.68 0.62–0.76 < 0.001 0.75 0.67–0.83 < 0.001
≥ 80 years 13.1 0.50 0.43–0.59 < 0.001 0.57 0.48–0.67 < 0.001
Sex
Female 20.5 Ref. Ref.
Male 20.4 0.99 0.93–1.07 0.865 0.93 0.86–1.00 0.042
Marital status
Cohabiting 21.1 Ref. Ref.
Single 19.3 0.89 0.83–0.96 0.002 0.93 0.86–1.00 0.057
Education
No university degree 19.6 Ref. Ref.
University degree 22.3 1.18 1.09–1.27 < 0.001 1.24 1.15–1.34 < 0.001
Smoking status
Not current smoker 19.4 Ref. Ref.
Current smoker 26.1 1.47 1.34–1.60 < 0.001 1.38 1.26–1.52 < 0.001
Experience of cancer (self and/or family/friend)
Yes 20.7 Ref. Ref.
No 19.0 0.90 0.82–0.98 0.020 0.85 0.77–0.93 0.001
Country
UK 22.5 Ref. Ref.
Australia 16.9 0.70 0.63–0.77 < 0.001 0.70 0.63–0.78 < 0.001
Canada 18.8 0.79 0.72–0.88 < 0.001 0.74 0.67–0.83 < 0.001
Denmark 21.3 0.93 0.82–1.05 0.229 0.88 0.78–1.00 0.053
Norway 24.9 1.14 1.01–1.28 0.031 1.10 0.97–1.24 0.137
Sweden 18.2 0.77 0.67–0.87 < 0.001 0.72 0.64–0.83 < 0.001
Test of moderation
Negative beliefs x Non-recognition of persistent cough or hoarseness 0.99 0.92–1.07 0.831
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bleeding across different levels of NCBs are depicted.
The predicted probability of a long anticipated patient
interval for those who recognised unexplained bleeding
as a possible cancer symptom increased with number of
NCBs. For those reporting four or more NCBs, the
predicted probability of a long anticipated patient
interval for rectal bleeding was the same regardless of
whether they recognised unexplained bleeding as a
cancer symptom or not. For those who did not
recognise unexplained bleeding as a cancer symptom,
the predicted probabilities for a long anticipated patient
interval for rectal bleeding decreased with increasing
number of NCBs.
Discussion
Main findings
Not recognising persistent cough/hoarseness and unex-
plained bleeding as possible signs of cancer and number
of NCBs were independently associated with an in-
creased likelihood of longer anticipated patient intervals
for persistent cough and rectal bleeding, respectively.
There was a dose-response relationship between number
of NCBs and longer anticipated patient intervals for per-
sistent cough and rectal bleeding. Hence, a high level of
NCBs may act as a barrier to help-seeking when experi-
encing a symptom that could be a sign of cancer. Fur-
thermore, we found that number of NCBs was an effect
moderator as when respondents reported four or more
NCBs, the risk of a long anticipated patient interval for
rectal bleeding would be the same whether the respond-
ent had recognised unexplained bleeding as a cancer
symptom or not. Number of NCBs could only be docu-
mented as an effect moderator in the model of bleeding
and not in the model of cough. Respondents estimated
that they would wait longer before seeking help for a
persisting cough than for rectal bleeding and in line with
this finding, respondents in another survey seldom
recognised cough or hoarseness as a cancer symptom
[14]. If respondents do not see persistent cough as a
“red flag” symptom in the same way they see rectal
bleeding, it seems plausible that the role of NCBs may
be different in the two models. The moderating potential
of NCBs may only come into play when the symptom is
experienced as serious and the symptom recognition
thereby causes anxiety [15].
We find it difficult to explain why the probability of a
long anticipated patient interval for rectal bleeding de-
creased with increasing number of NCBs among those
who did not recognise unexplained bleeding as a cancer
symptom. The number of respondents who did not rec-
ognise unexplained bleeding as a cancer symptom was
relatively small compared to those who did and there-
fore, when subdividing the group based on number of
NCBs, the confidence intervals became rather wide as
was evident in Fig. 2 and results from this analysis
should be interpreted with caution.
Strengths and limitations
Among the strengths of this study was the use of a
population-representative sample and that we used an
internationally validated questionnaire for assessing rec-
ognition of cancer symptoms and NCBs outcomes [12].
A potential weakness is that the anticipated help-seeking
interval was hypothetical and might not mirror the re-
sponse if a person experienced the symptom in reality.
The majority of respondents (61%) reported that they
would seek help immediately if they experienced rectal
bleeding, but a review of 38 studies examining patient
intervals in colorectal cancer showed that the actual me-
dian patient interval ranged from 7 days to 5 months
[16]. This suggests that at least some of the participants
in our study have underestimated how long they would
actually wait before seeking help. Further, since the
present data were cross-sectional, the causality of associ-
ations cannot be determined.
Comparisons with existing literature
Several other studies have found that lack of knowledge
of cancer symptoms is associated with longer anticipated
patient intervals [5] and actual patient intervals [2–4].
Table 3 Associations between recognition of persistent cough or hoarseness as cancer symptom, negative beliefs about cancer and
long anticipated patient interval for persistent cough (nadjusted = 19,277) (Continued)
Unadjusted Adjusted*
Outcome: long anticipated patient
interval for cough (> 1 month)
Outcome: long
anticipated patient
interval for cough
(> 1 month)
Proportion with
long interval (%)
OR 95% CI P-value OR 95% CI P-value
Likelihood-ratio test
LR chi2 0.05
P-value 0.831
*All independent variables were included in the same model
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Table 4 Associations between recognition of unexplained bleeding as cancer symptom, negative beliefs about cancer and long
anticipated patient interval for rectal bleeding (nadjusted = 19,695)
Unadjusted Adjusted*
Outcome: long anticipated
patient interval for rectal
bleeding (> 1 week)
Outcome: long anticipated
patient interval for rectal
bleeding (> 1 week)
Proportion with long interval (%) OR 95% CI P-value OR 95% CI P-value
Recognition of unexplained bleeding as cancer symptom
Yes 13.3 Ref. Ref.
No 19.7 1.59 1.41–1.79 < 0.001 1.90 1.58–2.30 < 0.001
Number of negative beliefs about cancer
0 13.0 Ref. Ref.
1 13.8 1.07 0.98–1.18 0.147 1.11 1.00–1.22 0.051
2 14.4 1.13 1.01–1.27 0.034 1.21 1.07–1.37 0.002
3 15.8 1.26 1.06–1.48 0.007 1.41 1.18–1.69 < 0.001
≥ 4 20.3 1.71 1.34–2.18 < 0.001 1.97 1.51–2.57 < 0.001
Age group
50–59 years 16.6 Ref. Ref.
60–69 years 14.0 0.82 0.75–0.90 < 0.001 0.82 0.75–0.90 < 0.001
70–79 years 11.4 0.65 0.58–0.73 < 0.001 0.67 0.59–0.76 < 0.001
≥ 80 years 8.5 0.46 0.39–0.56 < 0.001 0.51 0.41–0.62 < 0.001
Sex
Female 13.7 Ref. Ref.
Male 14.4 1.06 0.98–1.15 0.152 1.03 0.95–1.12 0.495
Marital status
Cohabiting 14.3 Ref. Ref.
Single 13.5 0.93 0.86–1.01 0.103 1.08 0.99–1.18 0.086
Education
No university degree 12.9 Ref. Ref.
University degree 16.4 1.33 1.22–1.44 < 0.001 1.29 1.18–1.41 < 0.001
Smoking status
Not current smoker 14.0 Ref. Ref.
Current smoker 13.9 1.00 0.90–1.12 0.990 0.91 0.81–1.02 0.111
Experience of cancer (self and/or family/friend)
Yes 14.2 Ref. Ref.
No 12.6 0.87 0.78–0.97 0.010 0.85 0.76–0.95 0.006
Country
UK 13.6 Ref. Ref.
Australia 8.6 0.59 0.52–0.68 < 0.001 0.60 0.52–0.68 < 0.001
Canada 15.1 1.13 1.01–1.27 0.033 1.04 0.93–1.17 0.480
Denmark 14.6 1.08 0.94–1.25 0.270 1.00 0.86–1.16 0.990
Norway 19.4 1.52 1.34–1.74 < 0.001 1.46 1.27–1.68 < 0.001
Sweden 17.1 1.31 1.14–1.50 < 0.001 1.22 1.06–1.41 0.005
Test of moderation
Negative beliefs x Non-recognition
of unexplained bleeding
0.84 0.75–0.95 0.005
Likelihood-ratio test
LR chi2 7.97
P-value 0.005
*All independent variables were included in the same model
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The influence of NCBs on length of the patient interval
has been less frequently studied. Qualitative studies have
found that negative expectations of the health care pro-
fessional make patients with potentially malignant oral
symptoms more likely to postpone help-seeking [17],
that older women (≥ 65 years) were deterred from seek-
ing help because of negative expectations to surgical and
medical treatments [18] and that poor confidence in the
healthcare system was a reason for not seeking help
when experiencing cancer alarm symptoms [19]. Further,
a review of 32 qualitative studies revealed that a fatalistic
attitude to cancer was one of the main reasons for delay-
ing help-seeking as well as interpreting symptoms as be-
nign and self-limiting [20].
The Extended Parallel Process Model (EPPM) [21, 22]
may be useful for explaining the moderating effect of
NCBs on the increased likelihood of longer anticipated
patient intervals for potential colorectal symptoms.
Thus, recognition of a symptom as a possible sign of
cancer may give rise to fear, which has been identified as
a barrier to help-seeking as well as a factor which could
promote prompt help-seeking for cancer symptoms [19,
23]. According to the EPPM, fear will induce protective
danger control processes (e.g. fast help-seeking) only if
the individual believes that s/he is able to deal with the
threat [21, 24]. If NCBs about the disease and its treat-
ment are salient and the individual believes that no ac-
tion will be effective dealing with the disease, the fear
will induce fear control processes such as denial and
downplay of worrisome symptoms, meaning that help-
seeking may be postponed.
Conclusion
It is often assumed that patients with sufficient know-
ledge about possible cancer symptoms would engage in
appropriate help-seeking [6]. The results of the present
study support this notion, as people who recognised
cancer symptoms reported shorter anticipated patient
intervals compared to people who did not recognise
these symptoms as possible signs of cancer. Meanwhile,
a high number of NCBs also increased the likelihood of
long anticipated patient intervals, and the association be-
tween recognition of unexplained bleeding as a cancer
symptom and the intention to seek help quickly for rec-
tal bleeding was only seen in respondents who reported
few NCBs. Therefore, it is equally important that NCBs
are addressed in interventions designed to shorten pa-
tient intervals.
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